N-Power Medicine raised $72 Million in a Series B funding round led by Merck Global Health Innovation Fund

Jul 01, 2024•over 1 year ago

Amount Raised

$72 Million

Round Type

series b

Redwood CityTherapeuticsPharmaceuticalMedicalBiotechnologyHealth Care

Investors

A Us Based Healthcare Focused InvestorMerck Global Health Innovation Fund

Description

N-Power Medicine, a clinical research and drug development platform company, has announced the initial close of its Series B funding round, with participation by a US-based healthcare focused investor. The funding round led by Merck Global Health Innovation Fund brings its total funding to date to $72 Million.

Company Information

Company

N-Power Medicine

Location

Redwood City, California, United States

About

N-Power Medicine is a clinical research and drug development platform company that aims to integrate clinical research and routine care into a single workflow. Founded in 2021, it aims to boost clinical trial participation to accelerate oncology drug development. The company's platform includes The Kaleido Registry, a collection of prospective, real-time, standardized patient data designed to support clinical trials and drug development.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends